Sami Hiemer, PhD
About Sami Hiemer, PhD
Sami Hiemer, PhD, is the Manager of Medical Writing at Alkermes, with extensive experience in medical and regulatory writing, scientific research, and mentoring.
Company
Sami Hiemer, PhD, is currently employed at Alkermes as a Manager, Medical Writing. Alkermes is a global biopharmaceutical company that focuses on developing innovative medicines for central nervous system diseases.
Title: Manager, Medical Writing
In his role at Alkermes, Sami Hiemer oversees the creation and management of medical writing documents. These documents are critical for regulatory submissions, communication with stakeholders, and supporting the development and approval of therapeutic products.
Education and Expertise
Sami Hiemer earned his Doctor of Philosophy (PhD) in Biochemistry from Boston University School of Medicine, where he studied from 2010 to 2015. He also holds a Bachelor of Science (BS) in Biochemistry from the University of Nebraska-Lincoln, earned between 2006 and 2010. His academic background is complemented by several publications in peer-reviewed journals focused on immunometabolism and cancer biology.
Background
Sami Hiemer has extensive experience in the biopharmaceutical industry, having worked in various capacities since 2008. He began his career as an Undergraduate Research Fellow at the University of Nebraska–Lincoln. He later served as a Summer Research Intern at Pfizer in Lincoln, Nebraska, and a PhD Candidate and Teaching Assistant at Boston University. His professional experience includes roles at Pfizer, Rheos Medicines, Inc., Third Rock Ventures, and Ora, Inc. Before joining Alkermes, he was a Senior Medical/Regulatory Writer at Immunocore.
Achievements
Throughout his career, Sami Hiemer has made significant contributions to the field of biochemistry and regulatory science. He has published multiple peer-reviewed articles in immunometabolism and cancer biology and has presented his research at international conferences like the American Association for Cancer Research (AACR) Annual Meeting. He received the Pfizer Postdoctoral Fellowship Award for outstanding research in inflammation and immunology. Additionally, he has served as a reviewer for scientific journals and contributed to successful IND submissions.